ID

26029

Descripción

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Anaphylaxis diagnosis - Repeating form (Scheduled visits)

Palabras clave

  1. 4/10/17 4/10/17 -
  2. 16/10/17 16/10/17 -
  3. 23/10/17 23/10/17 -
  4. 1/1/18 1/1/18 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

4 de octubre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Anaphylaxis diagnosis Repeating form GSK study Chronic Coronary Heart Disease NCT00799903

Anaphylaxis diagnosis Repeating form GSK study Chronic Coronary Heart Disease NCT00799903

Anaphylaxis diagnosis
Descripción

Anaphylaxis diagnosis

1. Event number
Descripción

[read-only]

Tipo de datos

text

2. Event
Descripción

Record the same event diagnosis, start date and time as the corresponding Non-serious Adverse Event or Serious Adverse Event form. If reaction is to a known or likely allergen, specify the allergen in the diagnosis

Tipo de datos

text

3. Start Date
Descripción

Start Date

Tipo de datos

date

3. Start Time
Descripción

Start Time

Tipo de datos

time

4. Event type
Descripción

Event type

Tipo de datos

text

If Type A, did the subject meet the following criteria: Reduced BP (systolic BP of less than 90 mmHg or greater than 30% decrease from that person's baseline)
Descripción

(if yes, subject meets diagnostic criteria for anaphylaxis)

Tipo de datos

boolean

If Type A, did the subject meet the following criteria: Exposure-to-reaction time
Descripción

(if yes, subject meets diagnostic criteria for anaphylaxis)

Tipo de datos

integer

If Type B, did the subject meet the following criteria: Involvement of the skin-mucosal tissue (e.g., generalised hives, itch-flush, swollen lips-tongue-uvula)
Descripción

(if yes to 2 or more, subject meets diagnostic criteria for anaphylaxis)

Tipo de datos

boolean

If Type B, did the subject meet the following criteria: Respiratory compromise (e.g., dyspnea, wheeze-bronchospasm, stridor, reduced PEF, hypoxemia)
Descripción

(if yes to 2 or more, subject meets diagnostic criteria for anaphylaxis)

Tipo de datos

boolean

If Type B, did the subject meet the following criteria: Reduced BP or associated symptoms (e.g., hypotonia [collapse], syncope, incontinence)
Descripción

(if yes to 2 or more, subject meets diagnostic criteria for anaphylaxis)

Tipo de datos

boolean

If Type B, did the subject meet the following criteria: Persistent gastrointestinal symptoms (e.g., crampy abdominal pain, vomiting)
Descripción

(if yes to 2 or more, subject meets diagnostic criteria for anaphylaxis)

Tipo de datos

boolean

If Type B, did the subject meet the following criteria: Exposure-to-reaction time
Descripción

(if yes to 2 or more, subject meets diagnostic criteria for anaphylaxis)

Tipo de datos

integer

If reaction was not related to an allergen, did the subject meet the following criteria: Acute onset of an illness (minutes to several hours) with involvement of the skin, mucosal tissue, or both (e.g., generalised hives, pruritis or flushing, swollen lips-tongueuvula)
Descripción

(if yes to acute onset of illness, AND 1 or more questions below, subject meets diagnostic criteria for anaphylaxis)

Tipo de datos

boolean

If reaction was not related to an allergen, did the subject meet the following criteria: Reduced blood pressure (BP) or associated symptoms of end-organ dysfunction (e.g., hypotonia [collapse], syncope, incontinence)
Descripción

(if yes to acute onset of illness, AND 1 or more questions below, subject meets diagnostic criteria for anaphylaxis)

Tipo de datos

boolean

If reaction was not related to an allergen, did the subject meet the following criteria: Respiratory compromise (e.g., dyspnea, wheeze-bronchospasm, stridor, reduced peak expiratory flow (PEF), hypoxemia)
Descripción

(if yes to acute onset of illness, AND 1 or more questions below, subject meets diagnostic criteria for anaphylaxis)

Tipo de datos

boolean

5. Did this event meet diagnostic criteria for anaphylaxis?
Descripción

If yes, complete the Hypersensitivity Reaction Record

Tipo de datos

boolean

Similar models

Anaphylaxis diagnosis Repeating form GSK study Chronic Coronary Heart Disease NCT00799903

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Anaphylaxis diagnosis
Event number
Item
1. Event number
text
Event
Item
2. Event
text
Start Date
Item
3. Start Date
date
Start Time
Item
3. Start Time
time
Item
4. Event type
text
Code List
4. Event type
CL Item
Type A: Reaction occurred rapidly after exposure to known allergen for this subject (minutes to several hours) (G)
CL Item
Type B: Reaction occurred rapidly after exposure to likely allergen for this subject (minutes to several hours) (H)
CL Item
Reaction was not related to an allergen for this subject (I)
Reduced blood pressure
Item
If Type A, did the subject meet the following criteria: Reduced BP (systolic BP of less than 90 mmHg or greater than 30% decrease from that person's baseline)
boolean
Item
If Type A, did the subject meet the following criteria: Exposure-to-reaction time
integer
Code List
If Type A, did the subject meet the following criteria: Exposure-to-reaction time
CL Item
<30 minutes (1)
CL Item
30-60 minutes (2)
CL Item
1-3 hours (3)
CL Item
>3 hours (4)
Involvement of the skin-mucosal tissue
Item
If Type B, did the subject meet the following criteria: Involvement of the skin-mucosal tissue (e.g., generalised hives, itch-flush, swollen lips-tongue-uvula)
boolean
Respiratory compromise Type B
Item
If Type B, did the subject meet the following criteria: Respiratory compromise (e.g., dyspnea, wheeze-bronchospasm, stridor, reduced PEF, hypoxemia)
boolean
Reduced BP or associated symptoms
Item
If Type B, did the subject meet the following criteria: Reduced BP or associated symptoms (e.g., hypotonia [collapse], syncope, incontinence)
boolean
Persistent gastrointestinal symptoms
Item
If Type B, did the subject meet the following criteria: Persistent gastrointestinal symptoms (e.g., crampy abdominal pain, vomiting)
boolean
Item
If Type B, did the subject meet the following criteria: Exposure-to-reaction time
integer
Code List
If Type B, did the subject meet the following criteria: Exposure-to-reaction time
CL Item
<30 minutes (1)
CL Item
30-60 minutes (2)
CL Item
1-3 hours (3)
CL Item
>3 hours (4)
Acute onset of an illness
Item
If reaction was not related to an allergen, did the subject meet the following criteria: Acute onset of an illness (minutes to several hours) with involvement of the skin, mucosal tissue, or both (e.g., generalised hives, pruritis or flushing, swollen lips-tongueuvula)
boolean
Reduced BP or associated symptoms of end-organ dysfunction
Item
If reaction was not related to an allergen, did the subject meet the following criteria: Reduced blood pressure (BP) or associated symptoms of end-organ dysfunction (e.g., hypotonia [collapse], syncope, incontinence)
boolean
Respiratory compromise
Item
If reaction was not related to an allergen, did the subject meet the following criteria: Respiratory compromise (e.g., dyspnea, wheeze-bronchospasm, stridor, reduced peak expiratory flow (PEF), hypoxemia)
boolean
diagnostic criteria for anaphylaxis met
Item
5. Did this event meet diagnostic criteria for anaphylaxis?
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial